NEUMEIER POMA INVESTMENT COUNSEL LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 192 filers reported holding HAEMONETICS CORP in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
NEUMEIER POMA INVESTMENT COUNSEL LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q4 2013$2,151,000
-65.3%
51,050
-67.1%
0.49%
-67.7%
Q3 2013$6,190,000
-39.0%
155,225
-36.7%
1.52%
-42.6%
Q2 2013$10,140,000245,2252.65%
Other shareholders
HAEMONETICS CORP shareholders Q3 2013
NameSharesValueWeighting ↓
Iron Triangle Partners LP 330,000$36,633,0004.66%
BEACONLIGHT CAPITAL, LLC 156,395$17,361,0002.80%
Bridge City Capital, LLC 48,011$5,330,0001.77%
Summit Creek Advisors LLC 121,362$13,472,0001.61%
Sivik Global Healthcare LLC 25,000$2,775,0001.01%
ANCHOR CAPITAL ADVISORS LLC 412,218$45,760,0000.97%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 69,655$7,732,0000.90%
Orbimed Advisors 852,000$94,581,0000.88%
LONDON CO OF VIRGINIA 1,057,738$117,420,0000.67%
WEXFORD CAPITAL LP 40,138$4,456,0000.66%
View complete list of HAEMONETICS CORP shareholders